Table.
Mice With Metabolic Syndrome Have Increased Periodontal Expression of Inflammatory Cytokines.
Mice | IL-6 | M-CSF | MCP-1 | RANKL |
---|---|---|---|---|
Non-MetS | ||||
With PBS | 0.18 (0.10, 1.59) | 0.69 (0.01, 1.68) | 0.04 (0.01, 0.23) | 1.38 (0.27, 3.30) |
With LPS | 0.82 (0.10, 1.98)a | 1.15 (0.40, 1.85)a | 0.11 (0.03, 0.37)a | 2.52 (0.55, 3.66)a |
MetS | ||||
With PBS | 0.73 (0.26, 1.96)b | 1.59 (0.92, 2.99)b | 0.42 (0.02, 1.28)b | 2.10 (0.74, 4.74)b |
With LPS | 1.09 (0.39, 2.61)c | 2.69 (1.57, 5.52)c | 1.20 (0.58, 4.58)c | 3.43 (1.19, 7.23)c |
Data are median (minimum, maximum) (n = 7). Mann-Whitney test was performed for statistical analysis.
IL-6, interleukin 6; LPS, lipopolysaccharide; MCP-1, monocyte chemoattractant protein 1; M-CSF, macrophage colony-stimulating factor; PBS, phosphate-buffered saline; RANKL, receptor activator of nuclear factor kappa-B ligand.
P < 0.01 vs. non-MetS mice with PBS injection.
P < 0.01 vs. non-MetS mice with PBS injection.
P < 0.01 vs. non-MetS mice with PBS injection. P < 0.05 vs. non-MetS mice with LPS. P < 0.05 vs. MetS mice with PBS.